Pelican Health Company Research Report

---

Company Overview

• Name: Pelican Health

• Mission: Empowering the Microbiome Health Movement; revolutionize the study of the small intestine and its microbiome through innovative, non-invasive medical devices.

• Founded: 2020

• Founders: Established due to the scientific work of the TIMC laboratory of the University Grenoble Alpes, led by four scientists and a medical technology company manager.

• Thomas SORANZO, PhD, CEO & Co-founder

• Arnaud MARIE, Chairman of the Board, Co-founder

• Philippe CINQUIN, MD, PhD, Co-founder

• Donald MARTIN, PhD, Co-founder

• Jean-Pierre ALCARAZ, PhD, Co-founder

• Key People:

• Thomas SORANZO, PhD, CEO

• Arnaud MARIE, Chairman of the Board

• Headquarters: 107 avenue Aristide Briand, 38600 Grenoble, France

• Number of Employees: 16

• Revenue: No information is available

• Known For: Development of a medical device that allows precise, non-invasive, in-situ sampling of the microbiome from the human intestine.

---

Products

Microbiome Sampling Device

• Description: An innovative ingestible medical device the size of a pharmaceutical pill for non-invasive sampling of the intestinal microbiome.

• Key Features:

• Allows multiple samplings in-situ through a single oral administration.

• Precision sampling from different intestinal locations.

• Non-invasive and simple to administer.

• Supports large scale collection and analysis of microbiomes.

• Use Process:

• Oral intake

• Passage through the stomach

• Sampling capsules release

• Sampling

• Retrieval

• Analysis

---

Recent Developments

• New Team Member:

• Appointment of Guillaume Goud as the new Chief Technology Officer (CTO) to enhance production, R&D, and company growth.

• Collaborative Projects:

• Participation in the INGRID collaborative project aimed at validating a new non-invasive sampling device for human small intestine microbiome, in partnership with Université Clermont Auvergne and the LyREC Clinical Research Center.

• Investment and Financial Expansion:

• Securement of new investments from French and Belgian investors, supporting the microbiome revolution mission.

• Recognition and Events:

• Participation in the Pharmabiotics Conference & Partnering 2024.

• Selected among the 100 startups to invest in 2024 by the magazine Challenges in categories MedTech and Biotech.

• Partnerships:

• Collaborations with major institutes and companies in scientific and industrial realms to augment growth.

• Innovations & Research:

• Presentation of preliminary results from the clinical investigation of the ingestible sampling device.

• Ongoing engagement in groundbreaking clinical investigations.

---

Additional Information

• Website: [Pelican Health](http://www.Pelican-Health.com)

• LinkedIn Presence: Engages actively with a following of 1543 on LinkedIn, sharing updates on innovations, projects, and industry engagements.

---

This structured analysis provides significant insights into Pelican Health, capturing the essence of its efforts in medical innovations within the microbiome sector, while focusing on the practical applications impacting health and patient diagnosis.